Page 39 - SOGIBA 1 2020

COMENTARIO BIBLIOGRÁFICO
S O G I B A
1
Médica ginecóloga. Miembro
titular de SAEGRE y SOGIBA.
2
Médica ginecóloga,
presidente de la SAEGRE.
3
Médica ginecóloga. Secretaria
académica de SAEGRE.
4 y una descripción de 3 casos: tumor de Leydig, tumor de cé-
Médico ginecólogo.
Presidente
de andrógenos. 4 2
Tumores ováricos secretores
1
MARIA BELEN PEREZ LANA , SANDRA DEMAYO ,
3
ADRIANA MONASTERO , MANIEL NÖLTING .
Secretory ovarian tumors androgen.
Minerva Ginecol. 2019 Feb;71(1):72-77. doi: 10.23736/S0026-
4784.18.04302-2. Epub 2018 Oct 2.
SUMMARY
Background: The sex cord-stromal tumors are relative
rare, comprising 5-8% of all ovarian neoplasms.
METHODS: The study androgen tumors and a description
of three cases: Leydig tumor, steroid cell (NOS) tumor and
Sertoli-Leydig tumor.
Results: Twelve patients were menopausal and one
patient of reproductive age. In all cases, regardless of the
histological variety, women presented symptoms of hyperan-
drogenism and virilization. All had increased values of total
testosterone. In all cases surgical treatment was performed,
with favorable clinical and biochemical evolution.
Conclusions: Sex cord stromal tumors of the ovary are
rare, and can be characterized by virilization for most patients.
The majority of the tumors are benign, with few cases having
low-grade malignancy. The suspicion and correct evaluation
of these women will lead to an early diagnosis and improve
their quality of life.
RESUMEN
Introducción: Los tumores de los cordones sexuales y
del estroma son relativamente raros, comprenden entre el 5
y el 8% de todas las neoplasias ováricas.
Objetivo: Revisión de 13 casos de tumores de andrógenos
lulas esteroides (NOS) y tumor de Sertoli-Leydig.